Archive for the ‘Treatment’ Category

Top Killer for Chronic Lyme is Suicide

https://themighty.com/2017/09/lyme-disease-suicide/

The Importance of Reaching Out If Lyme Disease Has Left You Feeling Suicidal

By Annie Perkins-Rosenberg

Editor’s note: If you experience suicidal thoughts, the following post could be potentially triggering. You can contact the Crisis Text Line by texting “START” to 741-741.

Article excerpt:

The important message of this article is to help those out there who deal with the psychiatric manifestations, the judgments and the daily struggle of living life with a complex disease like Lyme. It can be heavy some days, and anyone can have dark questioning moments pass through their minds. When those moments do arise, it can be complicated to find someone to trust and to talk to. Quite often, Lyme patients are paying for treatments out of pocket and this does not leave much money left for proper psychiatric help. With the limited time in office visits with our doctors, there is not much time left to talk about how we are feeling emotionally, and our doctors are generally not trained psychiatrists, as much as we wish they were. With Lyme disease being largely unknown, others close to you may judge you and you may feel like there is no one left to talk to. Even if there is, the psychiatric disturbances the disease can cause can make you feel like there is no one out there who can understand you, no one who can listen to you and no one to reach out to, but there is. There always is.

One of the techniques the author used was Googling the suicide prevention hotline so she had a plan if things got dark.  She also removed anything bothersome and overwhelming to her, set boundaries, learned to speak up, and found a small group of people on the same journey as her for comfort.  She also reminded herself that each day she was getting better, that she was healthy and could beat this.  When the dark thoughts came, she sought out help.

All, great advice.

The following abstract by Dr. Bransfield is telling:

LAD contributed to suicidality, and sometimes homicidality, in individuals who were not suicidal before infection. A higher level of risk to self and others is associated with multiple symptoms developing after acquiring LAD, in particular, explosive anger, intrusive images, sudden mood swings, paranoia, dissociative episodes, hallucinations, disinhibition, panic disorder, rapid cycling bipolar, depersonalization, social anxiety disorder, substance abuse, hypervigilance, generalized anxiety disorder, genital–urinary symptoms, chronic pain, anhedonia, depression, low frustration tolerance, and posttraumatic stress disorder. Negative attitudes about LAD from family, friends, doctors, and the health care system may also contribute to suicide risk.

By indirect calculations, it is estimated there are possibly over 1,200 LAD suicides in the US per year.

http://  Approx 1 Min

Robert Bransfield, MD, DLFAPA, private practice, Psychiatry, in Red Bank, New Jersey, discusses direct methods that can be used to acquire statistics related to suicides that are a result of Lyme and associated diseases

For more:

One of the best pieces of advice I got on the journey from another patient was, “don’t get depressed about being depressed.”  In other words, accept the fact there will be dark days with dark thoughts.  Don’t beat up on yourself over this.  Accept it and look forward to tomorrow which will be better.

While the topics regarding Lyme/MSIDS are endless, dealing with pain and insomnia are two issues that can really help with mental health.

For more:

I would be amiss if I didn’t mention detoxing at this point as well as not detoxing properly can also lead to pain:

Category:

Lyme, Psychological Aspects, research, Treatment

Lyme Disease Triggers Inflammation in “Hindbrain”

https://danielcameronmd.com/lyme-disease-inflammation-hindbrain/

Lyme disease triggers inflammation in “hindbrain”

lyme-disease-inflammation-brain

A 52-year-old woman was hospitalized with rhombencephalitis (inflammation of the rhombencephalon, also known as the hindbrain). The condition was found to be triggered by an infection with Borrelia burgdorferi, the causative agent of Lyme disease.

By

In their article, “Neuroborreliosis with involvement of rhombencephalon: A case report,” ¹ Svingen and colleagues describe a unique presentation in which Lyme disease triggered inflammation of the rhombencephalon, a region of the brain also referred to as the hindbrain.

Over an 8-month period, the patient experienced intermittent fevers, dry cough, fatigue, headaches, night sweats, unintentional weight loss of about 15 lbs., double vision, a tremor in the neck, paresthesia and tremor in the extremities, an unsteady gait, and memory loss.

Approximately 4 weeks prior to symptom onset, the woman had been vacationing in a Lyme-endemic region of Norway. However, she did not recall a tick bite or rash.

“An MRI scan demonstrated pathology in rhombencephalon with quite symmetric T2 hyperintensity involving capsula interna bilaterally, extending through mesencephalon to pons,” the authors wrote.

Borrelia burgdorferi-specific IgM and IgG antibodies were identified using Chemiluminescence Immunoassay (CLIA).

An MRI scan revealed inflammation in rhombencephalon (also referred to as the hindbrain) that are extremely rare in patients with Lyme disease, the authors wrote.

The patient was treated successfully for 4 weeks with intravenous ceftriaxone.

“The MRI findings in rhombencephalon had almost disappeared,” according to the authors. Seven months later, a follow-up MRI “was completely normal, and she had further improvement of her symptoms.”

The authors suggest, “Significant improvement of neurological symptoms and resolution of the MRI findings after proper treatment confirmed the diagnosis neuroborreliosis with rhombencephalitis.”

Furthermore, “we recommend that neuroborreliosis should be considered among the differential diagnoses in patients where neurological symptoms and findings suggesting inflammation in the CNS, despite unusual or normal neuroimaging findings.”

Rhombencephalitis can be caused by infections with Listeria monocytogenes as the most common agent followed by Enterovirus 71 and Herpes simplex virus, the authors wrote. However, it is “exceedingly rare” to find Borrelia burgdorferi as an infectious cause of rhombencephalitis.
References:
  1. Svingen H, Orrem J, Nørgaard Eskesen A. Neuroborreliosis with involvement of rhombencephalon: A case report. IDCases. 2022;28:e01472. Published 2022 Mar 8. doi:10.1016/j.idcr.2022.e01472

___________________

**Comment**

Please remember everything is considered “rare” regarding Lyme, even though many may have the symptoms.  They are rarely recorded.  Big difference.

For more:

Category:

Lyme, research, Treatment

More Boys Die After COVID Shot & FDA Approves Remdesivir For Kids

https://thevaccinereaction.org/2022/04/another-two-boys-died-in-their-sleep-days-after-receiving-second-covid-19-vaccine/  News Video Here (Approx. 2 Min)

Another Two Boys Died in Their Sleep Days After Receiving Second COVID-19 Vaccine

by NTD News
Published April 25, 2022
Just days after getting their second COVID-19 vaccine, two teenage boys died in their sleep. Medical experts have been investigating what happened and have now released their report. An epidemiologist says it adds to a body of evidence that confirms Pfizer’s vaccine can lead to death in children.
This sad news after the CDC admits 50% of the population has had COVID.  This percentage increases to 75% in children and adolescents, making anyone with a functioning brain question the need for a gene therapy injection for children that doesn’t stop infection or transmission, is filled with frighteningly toxic ingredients, and hasn’t shown any measurable impact upon mortality.

FDA Approves Remesivir For Babies

Despite the fact COVID poses little risk to children as well as a FOIA request showing the CDC can not provide a single confirmed COVID death in a child younger than 16, the FDA just approved toxic remdesivir for patients as young as 28 days and weighing 7 pounds.

Please see this powerful FLCCC graphic of remdesivir vs ivermectin.

Gilead, the manufacturer of remdsivir, announced by press release, (which appears to be the way science is now done in the ‘new normal) that there was clinical improvement at day 10. The study conveniently has no control group, making it impossible to compare effectiveness against standard of care and only included 53 children – three of whom died.  Adverse events were reported in 72% of the children, with 21% experiencing serious adverse events.
Possible adverse events:

  • elevated levels of liver enzymes
  • allergic reactions
  • fever
  • shortness of breath
  • rash
  • nausea
  • sweating
  • shivering

The drug is marketed under the name Veklury, but the clincher is that similarly to the COVID injections which are in a current clinical study with those receiving the injections being test subjects, a clinical study on infants using Veklury is also underway and also will not be completed until 2023.

This article goes through 5 studies the FDA uses to support remdesivir.  All of them show little if any benefit to hospitalized patients with moderate or severe disease.  It’s important to note that none of these studies looked at children or infants and only 8 subjects were under 18 – which means the FDA has ZERO data to support the drug in children.

So why is it approved?

Royalties go to Gilead, but a portion go NIAID, Tony Fauci’s agency and the US Army, which assisted with its development. I originally omitted the fact (appreciate the reminder) that Ralph Baric, UNC professor and the US’ premier coronavirus scientist, is not only a creator of ACE-2 humanized mice and chimeric SARS coronaviruses, he is also an inventor of Remdesivir and worked with the Moderna COVID vaccine beginning in December 2019 through NIAID, even before anyone knew there would be a pandemic.

Nearly everyone who is hospitalized in the US with COVID receives Remdesivir, because:

  1. hospitals get a financial bonus from the government for using it

  2. it is the top treatment recommended by the NIH Guidelines

    1. The Guidelines were created by a group that originally had 16 members with current or past financial ties to Gilead. The members of the guidelines group were handpicked by the 3 co-chairs. Clifford Lane, one of the co-chairs, is a Fauci deputy.  Source

This article states that nine on the panel of 65 have disclosed financial conflicts with Gilead.

Evidently some nurses refer to remdesivir as “Run, death is near.”

If you are new to the toxic world of remdesivir, that even the WHO admits is ineffective for COVID, please read the following articles:

Category:

Activism, Treatment, vaccines, Viruses

MS Drug Targeting EBV Shows Promise

https://www.medicalnewstoday.com/articles/multiple-sclerosis-ms-drug-targeting-epstein-barr-virus-shows-promise

Multiple sclerosis (MS): Drug targeting Epstein-Barr virus shows promise

  • Researchers are investigating the effects of a drug that targets the Epstein-Barr virus in people with multiple sclerosis (MS) in an ongoing phase 1 clinical trial.
  • The drug improves MS symptoms and may even reverse the condition.
  • The researchers are now recruiting for a Phase 2 clinical trial to further study the drug’s effects.

Multiple sclerosis (MS) is a chronic condition that affects the central nervous system (CNS). It is characterized by the immune system attacking myelin sheaths — fatty layers that surround nerve fibers and enable them to communicate.

A study published in early 2022 found that contracting the Epstein-Barr virus (EBV), a herpes virus, significantly increases a person’s risk of MS. Multiple studies have also found EBV-infected immune B cells in patients with MS.

Researchers still don’t know how EBV may increase MS risk. However, one study suggests that EBV proteins may mimic human myelin proteins and induce an immune reaction against myelin by CNS antigens.   (See link for article)

__________________

SUMMARY:

  • Atara Biotherapeutics, Inc. is in the middle of a Phase 1 clinical trial utilizing ATA118 that targets EBV-infected cells in people with MS.
  • Of 24 volunteers receiving varying doses, 20 showed improvement or halt in progression after 1 year.
  • Of 18 volunteers who took the drug for up to 39 months, half achieved sustained disability improvement with 7 showing signs of remyelination
  • Results will be presented at a conference by Atara on October 13th, 2022.
  • A188 might:
    • Interrupt cell-mediated autoimmune cascade driven by EBV-infected B cells.
    • Reduce the production of myelin-targeted antibodies made by EBV-infected plasma cells.
  • No serious or fatal side-effects were experienced, although one volunteer suffered a relapse.
  • Higher doses led to greater clinical responses.
  • The small sample size requires further research.
  • Atara is actively recruiting for a randomized, Phase 2, double-blind, placebo-controlled trial.

Important quote:

“A majority of persons with MS appear to have been exposed to EBV. There is a protein on the EBV that is the same as a protein in myelin. When the body’s immune system attacks the virus, it also ends up attacking the myelin. Clearing the virus would decrease the stimulus for the immune cells to attack the myelin.” ~ Barbara Giesser, MD, neurologist and MS specialist

Category:

research, Treatment

Nurse Freedom Network Founder Exposes Deadly Hospital COVID Protocols

https://thenewamerican.com/nurse-freedom-network-founder-exposes-hospital-covid-protocols  Video Here (Approx. 9 Min)

Nurse Freedom Network Founder Exposes Hospital COVID Protocols

by Christian Gomez
Kimberly Overton, the founder and CEO of Nurse Freedom Network, discusses how she left bedside nursing in the hospitals after witnessing firsthand how the hospital COVID protocols, specifically the use of remdesivir, often harmed and even killed patients, she tells The New American.
Overton describes how she saw patients die because of the remdesivir, the toxicity of the drug, and how hospitals receive financial incentives for administering it to patients.
In addition to exposing remdesivir, Nurse Freedom Network works to oppose vaccine mandates, help patients get lifesaving treatment, and to encourage other nurses to speak up.
For more:

Category:

Activism, Treatment, vaccines, Viruses